Evidence map›Paper›PMID 32625022›Full record

ReviewEngineering in life sciences2019

Recent advances in natural products exploitation in

Qiyuan Zhao, Liping Wang, Yunzi Luo

Abstract readReview
In one paragraph

Review in Engineering in life sciences, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 14 papers.

0numbers the graph read from it
0cells of the map it votes in
14citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

14 citing papers in PubMed.

  1. Article
  2. Review
  3. Article
  4. Genome mining of3 Biotech · 2022
    Article
  5. A Study of Type II ɛ-PL Degrading Enzyme (pldII) inInternational journal of molecular sciences · 2022
    Article
  6. Frontiers in microbiology · 2022
    Review
  7. 3 Biotech · 2021
    Review
  8. Review
  9. Article
  10. Recent Advances in Silent Gene Cluster Activation inFrontiers in bioengineering and biotechnology · 2021
    Review
  11. Article
  12. Efficient Multiplex Genome Editing inFrontiers in bioengineering and biotechnology · 2020
    Article
  13. Review
  14. Recent advances in natural products exploitation inEngineering in life sciences · 2019
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors.

Qiyuan ZhaoDepartment of Gastroenterology Cancer Center West China Hospital Sichuan University and Collaborative Innovation Center of Biotherapy Chengdu P. R. China.
Liping WangDepartment of Gastroenterology Cancer Center West China Hospital Sichuan University and Collaborative Innovation Center of Biotherapy Chengdu P. R. China.
Yunzi LuoDepartment of Gastroenterology Cancer Center West China Hospital Sichuan University and Collaborative Innovation Center of Biotherapy Chengdu P. R. China.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Natural products of microbial origin have proven to be the wellspring of clinically useful compounds for human therapeutics.

Indexed as

chassis engineeringheterologous expressionnatural productsStreptomycessynthetic biology

Identifiers

PMID32625022
PMCPMC6999378

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.